SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX)

NEW YORK, Feb. 27, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: AKRX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/akrx.

The investigation concerns whether Akorn and certain of its officers and/or directors have violated federal securities laws.

In April 2017, Fresenius Kabi, a division of Fresenius SE & Co. KGaA (collectively, "Fresenius"), and Akorn announced that Fresenius had agreed to acquire Akorn for approximately $4.3 billion.  On February 26, 2018, post-market, Fresenius announced that it is conducting an independent investigation, using external experts, into alleged breaches of U.S. Food and Drug Administration data integrity requirements relating to product development at Akorn.  Fresenius stated that "[t]he consummation of the transaction may be affected if the closing conditions under the merger agreement are not met."  Following this announcement, Akorn's share price has fallen sharply during intraday trading on February 27, 2018.

If you are aware of any facts relating to this investigation, or purchased Akorn shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/akrx.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC

Related Links

https://www.bgandg.com/